People: Genomic Health Inc (GHDX.OQ)
18 Apr 2019
Dr. Henry J. Fuchs M.D. serves as Independent Director of the Company., effective September 17, 2013. Dr. Fuchs was Executive Vice President and Chief Medical Officer of Onyx Pharmaceuticals, Inc., a biopharmaceutical company from September 2005 to December 2008 and served in multiple roles of increasing responsibility at Ardea Biosciences, Inc., a biotechnology company, first as Vice President, Clinical Affairs, then as President and Chief Operating Officer, and finally as President and Chief Executive Officer, from October 1996 until June 2005. From 1987 to 1996, Dr. Fuchs held various positions at Genentech Inc., a biotechnology company. Dr. Fuchs serves as a director of Mirati Therapeutics, Inc. Dr. Fuchs holds a B.A. in Biochemical Sciences from Harvard University, and an M.D. from George Washington University.
|Total Annual Compensation, USD||22,000|
|Restricted Stock Awards, USD||40,000|
|Long-Term Incentive Plans, USD||--|
|All Other, USD||132,727|
|Fiscal Year Total, USD||194,727|